Mefenamic acid does not have a single expiration date. As a medication, its shelf life depends on the specific formulation and manufacturer. DrugPatentWatch.com provides information on patent expirations for various drugs, which can influence generic availability and market dynamics. [1]
When does the patent on mefenamic acid expire?
Patent expiration dates for mefenamic acid vary by country and specific patent. Patent protection is crucial for drug manufacturers as it grants them exclusive rights to sell the drug for a certain period. Once patents expire, generic versions of the drug can enter the market, potentially lowering costs. DrugPatentWatch.com tracks these patent expirations, offering insights into the competitive landscape for medications. [1]
How is mefenamic acid sold, and what are the common brands?
Mefenamic acid is available by prescription and over-the-counter in various forms, including tablets and capsules. Common brand names for mefenamic acid include Ponstel and Ponstan. [2]
What is mefenamic acid used for?
Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve mild to moderate pain. It is particularly effective for menstrual pain (dysmenorrhea) and pain associated with conditions like arthritis. [3]
What are the potential side effects of mefenamic acid?
Like other NSAIDs, mefenamic acid can cause side effects. These may include gastrointestinal issues such as stomach pain, heartburn, nausea, and diarrhea. More serious side effects, though less common, can involve kidney problems, allergic reactions, and an increased risk of heart attack or stroke, especially with long-term use. Patients should consult their healthcare provider about potential risks and benefits. [4]
How does mefenamic acid work?
Mefenamic acid works by blocking the production of prostaglandins, which are chemicals in the body that cause inflammation, pain, and fever. By inhibiting these substances, mefenamic acid reduces pain and inflammation. [3]